# Staar Surgical Co (STAA)

> Cited company facts from SEC filings, by Steadybase. Web page: https://steadybase.io/company/staar-surgical-co/ JSON: https://steadybase.io/company/staar-surgical-co.json Checked Nov 10, 2026. Latest filing read: Nov 4, 2026.

## Company

- Legal name: STAAR SURGICAL CO
- Ticker: STAA (Nasdaq)
- SEC CIK: 0000718937
- Industry: Ophthalmic Goods (SIC 3851)
- Headquarters: Monrovia, CA
- Fiscal year ends: January 2
- SEC filer category: Large accelerated filer
- Website: staar.com
- LinkedIn: https://www.linkedin.com/company/staar-surgical
- Next earnings date: Feb 3, 2027 (estimated from past 8-K timing)

## Key facts

- Revenue: $239.4M for the fiscal year ended Jan 2, 2026 (10-K filed Mar 3, 2026). Source: https://www.sec.gov/Archives/edgar/data/718937/000071893726000004/0000718937-26-000004-index.html
- Operating income: -$91.7M for the fiscal year ended Jan 2, 2026 (10-K filed Mar 3, 2026). Source: https://www.sec.gov/Archives/edgar/data/718937/000071893726000004/0000718937-26-000004-index.html
- Net income: -$80.4M for the fiscal year ended Jan 2, 2026 (10-K filed Mar 3, 2026). Source: https://www.sec.gov/Archives/edgar/data/718937/000071893726000004/0000718937-26-000004-index.html
- SG&A: $274.1M for the fiscal year ended Jan 2, 2026 (10-K filed Mar 3, 2026). Source: https://www.sec.gov/Archives/edgar/data/718937/000071893726000004/0000718937-26-000004-index.html
- Employees: 957 as of Jan 2, 2026, as reported in an SEC filing. Source: https://www.sec.gov/Archives/edgar/data/718937/000071893726000004/staa-20260102.htm
- Shares outstanding: 50,201,819 as of Oct 30, 2026 (10-Q filed Nov 4, 2026). Source: https://www.sec.gov/Archives/edgar/data/718937/000071893726000041/0000718937-26-000041-index.html
- Auditor: Bdo Usa, P.C., Los Angeles, California, named in the latest 10-K. Source: https://www.sec.gov/Archives/edgar/data/718937/000071893726000004/staa-20260102.htm

## Business

STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. We are the leading manufacturer of phakic implantable lenses used worldwide in corrective or “refractive” surgery. We have been dedicated solely to ophthalmic surgery for over 40 years.

Source: Item 1. Business, https://www.sec.gov/Archives/edgar/data/718937/000071893726000004/staa-20260102.htm

## Annual results

| Fiscal year ended | Revenue | Operating income | Net income | SG&A |
|---|---|---|---|---|
| Jan 2, 2026 | $239.4M | -$91.7M | -$80.4M | $274.1M |
| Dec 27, 2024 | $313.9M | -$12.6M | -$20.2M | $252.2M |
| Dec 29, 2023 | $322.4M | $28.1M | $21.3M | $224.6M |
| Dec 30, 2022 | $239.4M | $43.8M | $39.7M | $179.6M |
| Dec 31, 2021 | $230.5M | $33.3M | $27.5M | $145.3M |

Each figure comes from the annual report for that year. Filing links for every figure: https://steadybase.io/company/staar-surgical-co.json

## Officers and directors

- Warren Foust, President and CEO. LinkedIn: https://linkedin.com/in/foust-warren. Source: Form 4 filed Aug 18, 2026, https://www.sec.gov/Archives/edgar/data/718937/000197077826000014/0001970778-26-000014-index.htm
- Deborah Andrews, Executive Vice President and Chief Financial Officer. LinkedIn: https://linkedin.com/in/deborah-andrews-5b484112. Source: 8-K filed Nov 4, 2026, https://www.sec.gov/Archives/edgar/data/718937/000071893726000040/staa-ex99_1.htm
- Deborah J. Andrews, Chief Financial Officer & EVP. Source: Form 4 filed Aug 18, 2026, https://www.sec.gov/Archives/edgar/data/718937/000132569726000011/0001325697-26-000011-index.htm
- David Bailey, Chief Commercial Officer. Source: 8-K filed Sep 10, 2026, https://www.sec.gov/Archives/edgar/data/718937/000119312526386662/staa-20260909.htm
- Magda Michna, Chief Development Officer. LinkedIn: https://linkedin.com/in/magdamichna. Source: Form 4 filed Aug 18, 2026, https://www.sec.gov/Archives/edgar/data/718937/000173148726000011/0001731487-26-000011-index.htm
- Nathaniel Sisitsky, Chief Legal Officer. Source: Form 4 filed Dec 12, 2025, https://www.sec.gov/Archives/edgar/data/718937/000119312525318018/0001193125-25-318018-index.htm
- Christopher Min Fang Wang, Director. Source: 10-K filed Mar 3, 2026, https://www.sec.gov/Archives/edgar/data/718937/000071893726000004/staa-20260102.htm
- Lilian Zhou, Director. Source: 10-K filed Mar 3, 2026, https://www.sec.gov/Archives/edgar/data/718937/000071893726000004/staa-20260102.htm
- Louis E. Silverman, Director. Source: 10-K filed Mar 3, 2026, https://www.sec.gov/Archives/edgar/data/718937/000071893726000004/staa-20260102.htm
- Neal C. Bradsher, Director. Source: 10-K filed Mar 3, 2026, https://www.sec.gov/Archives/edgar/data/718937/000071893726000004/staa-20260102.htm
- Richard T. LeBuhn, Director. Source: 10-K filed Mar 3, 2026, https://www.sec.gov/Archives/edgar/data/718937/000071893726000004/staa-20260102.htm
- Wei Jiang, Director. Source: 10-K filed Mar 3, 2026, https://www.sec.gov/Archives/edgar/data/718937/000071893726000004/staa-20260102.htm
- Arthur C. Butcher, Board member (per proxy). Source: DEF 14A filed May 4, 2026, https://www.sec.gov/Archives/edgar/data/718937/000071893726000015/staa-20260501.htm
- Christopher M. Wang, Board member (per proxy). Source: DEF 14A filed May 4, 2026, https://www.sec.gov/Archives/edgar/data/718937/000071893726000015/staa-20260501.htm
- Lilian Y. Zhou, Board member (per proxy). Source: DEF 14A filed May 4, 2026, https://www.sec.gov/Archives/edgar/data/718937/000071893726000015/staa-20260501.htm
- Magda Michna, PhD, Named in proxy. Source: DEF 14A filed May 4, 2026, https://www.sec.gov/Archives/edgar/data/718937/000071893726000015/staa-20260501.htm
- Nathaniel Sisitsky, Esq., Named in proxy. Source: DEF 14A filed May 4, 2026, https://www.sec.gov/Archives/edgar/data/718937/000071893726000015/staa-20260501.htm
- Stephen C. Farrell, Named in proxy. Source: DEF 14A filed May 4, 2026, https://www.sec.gov/Archives/edgar/data/718937/000071893726000015/staa-20260501.htm

## Recent 8-K events

- Nov 4, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/718937/000071893726000040/staa-20261104.htm
- Sep 10, 2026: Item 5.02, Departure or appointment of directors or officers; compensation; Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/718937/000119312526386662/staa-20260909.htm
- Aug 12, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/718937/000071893726000036/staa-20260812.htm
- Aug 6, 2026: Item 5.02, Departure or appointment of directors or officers; compensation; Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/718937/000119312526337197/staa-20260805.htm
- Jun 22, 2026: Item 5.02, Departure or appointment of directors or officers; compensation; Item 5.07, Submission of matters to a vote of security holders; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/718937/000071893726000029/staa-20240620.htm
- Jun 9, 2026: Item 5.02, Departure or appointment of directors or officers; compensation. Source: https://www.sec.gov/Archives/edgar/data/718937/000071893726000027/staa-20260609.htm
- May 13, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/718937/000071893726000022/staa-20260512.htm
- Apr 8, 2026: Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/718937/000071893726000009/staa-20260408.htm
- Mar 3, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 7.01, Regulation FD disclosure. Source: https://www.sec.gov/Archives/edgar/data/718937/000071893726000005/staa-20260303.htm
- Feb 5, 2026: Item 5.02, Departure or appointment of directors or officers; compensation. Source: https://www.sec.gov/Archives/edgar/data/718937/000119312526038534/staa-20260205.htm

## Insider trades (Form 4)

- Mar 13, 2026: Partners L.P. Broadwood (Director) bought 670,213 shares, about $12.3M. Source: https://www.sec.gov/Archives/edgar/data/718937/000091957426001617/0000919574-26-001617-index.htm
- Mar 13, 2026: Neal C. Bradsher (Director) bought 670,213 shares, about $12.3M. Source: https://www.sec.gov/Archives/edgar/data/718937/000091957426001617/0000919574-26-001617-index.htm

## What management said

- "Our record nine-month performance keeps us firmly on track to deliver strong full-year GAAP net income with free cash flow and a debt-free balance sheet" Deborah Andrews, Executive Vice President and Chief Financial Officer (8-K filed Nov 4, 2026). Source: https://www.sec.gov/Archives/edgar/data/718937/000071893726000040/staa-ex99_1.htm

## Latest filings

- 8-K filed Sep 10, 2026: https://www.sec.gov/Archives/edgar/data/718937/000119312526386662/staa-20260909.htm
- 10-K filed Mar 3, 2026: https://www.sec.gov/Archives/edgar/data/718937/000071893726000004/staa-20260102.htm
- 10-Q filed Aug 12, 2026: https://www.sec.gov/Archives/edgar/data/718937/000071893726000037/staa-20260703.htm
- DEF 14A filed May 4, 2026: https://www.sec.gov/Archives/edgar/data/718937/000071893726000015/staa-20260501.htm

## About this data

SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from.
Steadybase covers US-headquartered public companies that file with the SEC. API and MCP access: https://steadybase.io/docs/